ClinicalTrials.gg
CompletedNCT07820956Updated Sep 15, 2026

Ice Application for Oxacillin-Related Phlebitis and Pain

An interventional study of Ice Application and Room-Temperature Water-Bag Application in Peripheral Intravenous Phlebitis, Injection Site Pain and Pain, sponsored by Central Taiwan University of Science and Technology. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Central Taiwan University of Science and Technology · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 years 5 months after the study started (first participant enrolled Apr 2022, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated whether ice application could reduce pain and peripheral intravenous phlebitis associated with oxacillin administration. Hospitalized patients receiving intravenous oxacillin were assigned to either an ice application group or a control group. In the intervention group, ice was applied to the area around the peripheral intravenous catheter before oxacillin administration. In the control group, a room-temperature water bag was applied in the same manner. Pain after oxacillin administration and signs of phlebitis at the intravenous catheter site were assessed and compared between the two groups. The study aimed to determine whether ice application could provide a simple, non-pharmacological approach to reducing oxacillin-related pain and phlebitis.

02

Conditions studied

  • Peripheral Intravenous Phlebitis
  • Injection Site Pain
  • Pain

Browse trials for

Keywords

  • Oxacillin
  • Ice Application
  • Peripheral Intravenous Catheter
  • Phlebitis
  • Pain
  • Cryotherapy
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's enrollment of 86 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Central Taiwan University of Science and Technology is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults aged 20 to 60 years. Conscious and able to participate in the study. Intravenous injection site located on either hand. Receiving a single antibiotic medication during the study. Eligible regardless of sex or medical diagnosis.

Exclusion criteria

Exclusion Criteria:

Dementia. Psychiatric disorders. Skin rash at the study site. Purpura. Pregnancy. Current oral use. Hemodialysis. Administration of a second medication or an injection containing two or more medications during the study.

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Ice Application Group

    Participants assigned to this group received ice application around the peripheral intravenous catheter site before intravenous oxacillin administration.

    Other: Ice Application

  • Active comparator
    Room-Temperature Water-Bag Control Group

    Participants assigned to this group received a room-temperature water-bag application around the peripheral intravenous catheter site before intravenous oxacillin administration.

    Other: Room-Temperature Water-Bag Application

Interventions

  • OtherIce Application

    Ice was applied around the peripheral intravenous catheter site before intravenous oxacillin administration. The intervention was intended to reduce pain associated with oxacillin administration and the occurrence of peripheral intravenous phlebitis.

  • OtherRoom-Temperature Water-Bag Application

    A room-temperature water bag was applied around the peripheral intravenous catheter site before intravenous oxacillin administration as the control condition.

06

What researchers measure

Primary outcomes

  1. Pain Intensity After Intravenous Oxacillin Administration

    Pain intensity associated with intravenous oxacillin administration was assessed repeatedly after oxacillin administration across nine 8-hour intervals during the 72-hour observation period. Higher pain scores indicated greater pain intensity.

    Time frame: Up to 72 hours after intravenous oxacillin administration

  2. Pain Intensity After Intravenous Oxacillin Administration

    Pain intensity associated with intravenous oxacillin administration was assessed using a numerical rating scale, with higher scores indicating greater pain. Pain was assessed repeatedly after oxacillin administration across nine 8-hour intervals during the 72-hour observation period.

    Time frame: From 1 to 72 hours after initiation of the study intervention, assessed at 1-8, 9-16, 17-24, 25-32, 33-40, 41-48, 49-56, 57-64, and 65-72 hours.

07

Study locations

1 site
  • Feng Yuan Hospital, Ministry of Health and Welfare
    Fengyuan, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07820956
Lead sponsor
Central Taiwan University of Science and Technology
Responsible party
Kuan-Yu Lin (professor, Central Taiwan University of Science and Technology) — Principal investigator
First posted
Sep 15, 2026
Start date
Apr 7, 2022
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Sep 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion